Hap Trading, LLC Bristol Myers Squibb CO Call Options Transaction History

Hap Trading, LLC

$840 Billion
Q2 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $414,575 - $545,797	10,300 Added 60.95%	27,200 $22.1 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $522,981 - $592,960	-10,900 Reduced 39.21%	16,900 $26.4 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $751,440 - $896,675	15,500 Added 126.02%	27,800 $17.8 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $712,047 - $796,179	12,300 New	12,300 $713,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $854,229 - $968,890	13,000 Added 37.9%	47,300 $19,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $273,920 - $324,360	4,000 Added 13.2%	34,300 $54,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $260 - $153,680	-2,000 Reduced 6.19%	30,300 $74,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $1.66 Million - $1.99 Million	-27,000 Reduced 45.53%	32,300 $132,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.67 Million - $1.94 Million	-31,100 Reduced 34.4%	59,300 $145,000
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $792,878 - $928,754	13,400 Added 17.4%	90,400 $99,000
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $2.25 Million - $2.45 Million	36,400 Added 89.66%	77,000 $96,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $623,070 - $700,770	-10,500 Reduced 20.55%	40,600 $103,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $184,768 - $209,376	-3,200 Reduced 5.89%	51,100 $66,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $660,445 - $731,860	11,500 Added 26.87%	54,300 $114,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $679,768 - $794,716	-12,400 Reduced 22.46%	42,800 $161,000
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $57.7 Million - $83.9 Million	-1,244,200 Reduced 95.75%	55,200 $235,000
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $8.31 Million - $9.85 Million	194,200 Added 17.57%	1,299,400 $2.25 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $114 Million - $126 Million	-2,558,200 Reduced 69.83%	1,105,200 $894,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $160 Million - $191 Million	3,554,400 Added 3260.92%	3,663,400 $505,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $1.07 Million - $1.39 Million	-22,000 Reduced 16.79%	109,000 $20,000
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $27.3 Million - $31.5 Million	-456,200 Reduced 77.69%	131,000 $155,000
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $239,760 - $261,399	-4,000 Reduced 0.68%	587,200 $889,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $32.7 Million - $37.7 Million	591,200	591,200 $2.64 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account